Venturi Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-107
Closed -$16.4K – 711
2024
Q4
$16.4K Sell
107
-112
-51% -$18.9K ﹤0.01% 1304
2024
Q3
$42.5K Buy
219
+93
+74% +$19.5K ﹤0.01% 816
2024
Q2
$29.2K Buy
126
+58
+85% +$12.6K ﹤0.01% 830
2024
Q1
$14.7K Sell
68
-1
-1% -$234 ﹤0.01% 823
2023
Q4
$17.9K Buy
69
+4
+6% +$982 ﹤0.01% 727
2023
Q3
$16.7K Hold
65
– – ﹤0.01% 677
2023
Q2
$18.5K Hold
65
– – ﹤0.01% 560
2023
Q1
$18.1K Buy
+65
New +$18K ﹤0.01% 614
2019
Q1
– Sell
-1,097
Closed -$337K – 247
2018
Q4
$337K Buy
+1,097
New +$350K 0.05% 184

Other funds holding BIIB

Venturi Wealth Management's BIIB Position: Q1 2025 in Review

Venturi Wealth Management sold out of Biogen (BIIB) in Q1 2025, closing a stake of 107 shares — an estimated $16.4K sold.

Venturi Wealth Management first reported a position in BIIB in Q4 2018 and held it in 9 quarters. The position peaked at $337K in Q4 2018. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Venturi Wealth Management reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 107 Biogen shares in Q1 2025, an estimated $16.4K.
  • Venturi Wealth Management first reported a position in Biogen in Q4 2018 and held it in 9 quarters.
  • Venturi Wealth Management's Biogen position peaked at $337K in Q4 2018.
  • 883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.